Topics enriched in Samples 4 and 16 include genes such as AR, GRHL2, FOXA1, SLC43A1, WNT7B, which are known downstream players active in prostate cancers with ERG expression49,50. The gene discussed is FOXA1; the disease is prostate carcinoma.